Literature DB >> 15579092

Cellular physiology of mismatch repair.

X Wu1, Z Khalpey, M Cascalho.   

Abstract

The DNA mismatch repair system maintains genomic stability by correcting DNA sequence errors generated during DNA replication, during genetic exchanges between chromosomes i.e., recombination, and by correcting DNA lesions caused by mutagenic agents such as cis-platinum. Post-synthesis mismatch repair improves almost 1000-fold the fidelity of DNA replication; however, the functions of mismatch repair proteins extend well beyond DNA repair. Recent studies suggest that mismatch repair is part of the machinery that couples DNA damage and repair to cell cycle regulation and apoptosis. These studies indicate that tolerance to certain DNA lesions (such as methylation and cis-platinum adducts) is associated with inefficient activation of cell cycle checkpoints and inefficient activation of apoptosis in mismatch repair deficient cells. Hence, mismatch repair proteins regulate the survival threshold to DNA damage, and this function provides a novel platform for understanding the role of mismatch repair in B cells, in tumor formation, as well as in resistance to chemotherapy. In this communication, we review how mismatch repair may contribute to the physiology of cells and may be regulated by the intracellular trafficking of mismatch repair proteins.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15579092     DOI: 10.2174/1381612043382468

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  4 in total

1.  HOXA5 regulates hMLH1 expression in breast cancer cells.

Authors:  Sai Duriseti; Paul T Winnard; Yelena Mironchik; Farhad Vesuna; Ana Raman; Venu Raman
Journal:  Neoplasia       Date:  2006-04       Impact factor: 5.715

2.  Association between MSH6 G39E polymorphism and cancer susceptibility: a meta-analysis of 7,046 cases and 34,554 controls.

Authors:  Zuming Li; Lihua Kong; Ling Yu; Jiao Huang; Ke Wang; Shi Chen; Miao Yu; Sheng Wei
Journal:  Tumour Biol       Date:  2014-03-13

3.  Disruption of a mitochondrial MutS DNA repair enzyme homologue confers drug resistance in the parasite Toxoplasma gondii.

Authors:  Erin M Garrison; Gustavo Arrizabalaga
Journal:  Mol Microbiol       Date:  2009-03-04       Impact factor: 3.501

4.  Markers of chemoradiation resistance in patients with locally advanced head and neck squamous cell carcinoma, treated by intra-arterial carboplatin and concurrent radiation.

Authors:  L Mannarini; G Bertino; P Morbini; C Villa; M Benazzo
Journal:  Acta Otorhinolaryngol Ital       Date:  2007-08       Impact factor: 2.124

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.